These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 17133531

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis.
    Salvarani C, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi G, Catanoso MG, Boiardi L.
    J Rheumatol; 2005 Nov; 32(11):2173-7. PubMed ID: 16265697
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
    Salvarani C, Casali B, Boiardi L, Ranzi A, Macchioni P, Nicoli D, Farnetti E, Brini M, Portioli I.
    J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
    [Abstract] [Full Text] [Related]

  • 8. C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain.
    Palomino-Morales R, Vazquez-Rodriguez TR, Miranda-Filloy JA, Martin J, Gonzalez-Gay MA.
    J Rheumatol; 2009 Feb; 36(2):341-6. PubMed ID: 19040303
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association of CD24 gene polymorphisms with susceptibility to biopsy-proven giant cell arteritis.
    Rueda B, Miranda-Filloy JA, Martin J, Gonzalez-Gay MA.
    J Rheumatol; 2008 May; 35(5):850-4. PubMed ID: 18381780
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C.
    J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population.
    Combe B, Sany J, Le Quellec A, Clot J, Eliaou JF.
    J Rheumatol; 1998 Jan; 25(1):94-8. PubMed ID: 9458210
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
    Martin J, Perez-Armengol C, Miranda-Filloy JA, Vilchez JR, Lopez-Nevot MA, Garcia-Porrua C, Gonzalez-Gay MA.
    J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.